Staphylococcus aureus : Biofilm Formation and Strategies Against it
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Formation of Staphylococcus aureus biofilm causes significant infections in the human body. Biofilm forms through the aggregation of bacterial species and brings about many complications. It mediates drug resistance and persistence and facilitates the recurrence of infection at the end of antimicrobial therapy. Biofilm formation is completed in a series of steps, and any interference in these steps can disrupt its formation. Such interference may occur at any stage of biofilm production, including attachment, monolayer formation, and accumulation. Interfering agents can act as quorum sensing inhibitors and interfere in the functionality of quorum sensing receptors, attachment inhibitors, and affect cell hydrophobicity. Among these inhibiting strategies, attachment inhibitors could serve as the best agents against biofilm formation, because in case pathogens abort the attachment, the next stages of biofilm formation, e.g., accumulation and dispersion, will fail to materialize. Inhibition at this stage leads to suppression of virulence factors and invasion. One of the best knowing inhibitors is a chelator that collects metal, Fe+, Zn+, and magnesium critical for biofilm formation. These effective factors in the binding and formation of biofilm are investigated, and the coping strategy is discussed. This review examines the stages of biofilm formation and determines what factors interfere in the continuity of these steps. Finally, the inhibition strategies are investigated, reviewed, and discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Current pharmaceutical biotechnology - 23(2022), 5 vom: 04., Seite 664-678 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nasser, Ahmad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibiofilm agent |
|---|
| Anmerkungen: |
Date Completed 11.02.2022 Date Revised 11.02.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389201022666210708171123 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32784096X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32784096X | ||
| 003 | DE-627 | ||
| 005 | 20231225201656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389201022666210708171123 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM32784096X | ||
| 035 | |a (NLM)34238148 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nasser, Ahmad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Staphylococcus aureus |b Biofilm Formation and Strategies Against it |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.02.2022 | ||
| 500 | |a Date Revised 11.02.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Formation of Staphylococcus aureus biofilm causes significant infections in the human body. Biofilm forms through the aggregation of bacterial species and brings about many complications. It mediates drug resistance and persistence and facilitates the recurrence of infection at the end of antimicrobial therapy. Biofilm formation is completed in a series of steps, and any interference in these steps can disrupt its formation. Such interference may occur at any stage of biofilm production, including attachment, monolayer formation, and accumulation. Interfering agents can act as quorum sensing inhibitors and interfere in the functionality of quorum sensing receptors, attachment inhibitors, and affect cell hydrophobicity. Among these inhibiting strategies, attachment inhibitors could serve as the best agents against biofilm formation, because in case pathogens abort the attachment, the next stages of biofilm formation, e.g., accumulation and dispersion, will fail to materialize. Inhibition at this stage leads to suppression of virulence factors and invasion. One of the best knowing inhibitors is a chelator that collects metal, Fe+, Zn+, and magnesium critical for biofilm formation. These effective factors in the binding and formation of biofilm are investigated, and the coping strategy is discussed. This review examines the stages of biofilm formation and determines what factors interfere in the continuity of these steps. Finally, the inhibition strategies are investigated, reviewed, and discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biofilm | |
| 650 | 4 | |a EPS | |
| 650 | 4 | |a PIA. | |
| 650 | 4 | |a Staphylococcus | |
| 650 | 4 | |a antibiofilm agent | |
| 650 | 4 | |a biofilm inhibitor | |
| 650 | 4 | |a dispersion | |
| 650 | 7 | |a Virulence Factors |2 NLM | |
| 700 | 1 | |a Dallal, Mohammad Mehdi Soltan |e verfasserin |4 aut | |
| 700 | 1 | |a Jahanbakhshi, Shiva |e verfasserin |4 aut | |
| 700 | 1 | |a Azimi, Taher |e verfasserin |4 aut | |
| 700 | 1 | |a Nikouei, Leila |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d 2000 |g 23(2022), 5 vom: 04., Seite 664-678 |w (DE-627)NLM11369072X |x 1873-4316 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:5 |g day:04 |g pages:664-678 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389201022666210708171123 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2022 |e 5 |b 04 |h 664-678 | ||